{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-001082","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2022-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.387551+00:00","generated_at":"2026-06-23T11:48:10.002752+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"IGC shareholders elect directors, ratify auditor, approve 3M share grant","bullets":["Ram Mukunda, James Moran elected Class C directors until 2025; Claudia Grimaldi elected Class A director until 2023.","Ratified Manohar Chowdhry & Associates as independent auditor for fiscal 2023.","Approved grant of 3,000,000 common shares to employees, advisors, directors under performance/vesting metrics.","Total shares voted: 35,103,116 (67.40% of outstanding); broker non-votes 11,861,428."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-001082","json":"https://secwatch.observer/filing/0001185185-22-001082.json","markdown":"https://secwatch.observer/filing/0001185185-22-001082.md","text":"https://secwatch.observer/filing/0001185185-22-001082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/indiaglob20220909_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:48:10.002752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0845924318","claim":"Ram Mukunda was elected as Class C Director at IGC Pharma, Inc..","evidence_excerpt":"On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class C Director"}],"fact_type":"executive_change"},{"claim_id":"7b938f7fd7","claim":"Claudia Grimaldi was elected as Class A Director at IGC Pharma, Inc..","evidence_excerpt":"and Ms. Claudia Grimaldi was elected to the Company’s Board of Directors at the Annual Meeting, to serve as a Class A director, until the 2023 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class A Director"}],"fact_type":"executive_change"},{"claim_id":"f816e743f0","claim":"James Moran was elected as Class C Director at IGC Pharma, Inc..","evidence_excerpt":"On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class C Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}